HealthStream (HSTM) Stock: Buy, Sell, or Hold?
HSTM - HealthStream Inc
$33.51
-0.26 (-0.77%)
▼
5d:
-0.42%
30d:
+15.51%
90d:
+26.98%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 02, 2026
10d
Get Alerted When HSTM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: HSTM shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: HSTM shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$39.76
Based on 12.6% avg growth
INTRINSIC VALUE TODAY
$24.69
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HSTM is currently trading at $33.51, which is considered extended relative to its 30-day fair value range of $29.20 to $32.99. From a valuation perspective, the stock is trading at a premium (Forward PE: 37.9) compared to its historical average (29.1). At these levels, the market is pricing in 9.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, HSTM is in a strong uptrend. The price is approaching resistance at $34.48. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: HSTM scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HSTM is in a strong uptrend. The price is approaching resistance at $34.48. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: HSTM scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$29.20 -
$32.99
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
22.9%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (20/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($35.00)
- NEUTRAL: Trading at premium valuation - market expects 9.2% growth which is achievable
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$29.20 -
$32.99
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$31.91
Resistance Level
$34.48
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
37.86
Wall Street Target
$35.00
(+4.4%)
Revenue Growth (YoY)
12.5%
Earnings Growth (YoY)
28.4%
Profit Margin
6.6%
Valuation Premium vs History
+9.2% premium
PE vs Historical
37.9 vs 29.1
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.2%
(market-implied from PE analysis)
1-Year Target
$36.59
(+9%)
2-Year Target
$39.96
(+19%)
3-Year Target
$43.64
(+30%)
3-Yr Target (if PE normalizes)
(PE: 38→29)
PE COMPRESSION
$33.54
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 37.9, Growth: 21.2%)
$59.71
(+78%)
Base:
(SPY PE: 19.9, Growth: 21.2%)
$31.32
(-7%)
Bear:
(PE: 16.9, Growth: 21.2%)
$26.62
(-21%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (47x PE), but valuation improves significantly next year (38x PE) as earnings recover.
Trailing PE: 46.90 | Current EPS (TTM): $0.72
Bull Case
$45.66
(+36%)
Analyst growth 22.9%, PE expands to 51.6
Base Case
$41.51
(+24%)
Market implied 22.9%, PE stable at 46.9
Bear Case
$22.96
(-32%)
Severe decline -20.0%, PE contracts to 39.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 21, 2026 10:13 PM ET
Data refreshes hourly during market hours. Next update: 11:13 PM
Data refreshes hourly during market hours. Next update: 11:13 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HSTM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
29 analysts |
$297 | 30 SELL |
|
BTSG
BrightSpring Health Serv… |
STRONG BUY
18 analysts |
$79 | 51 HOLD |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
23 analysts |
$34 | 33 SELL |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 40 SELL |
|
HNGE
Hinge Health, Inc. |
STRONG BUY
17 analysts |
$112 | 39 SELL |
